The B-SPATIAL-Registry will provide a tool of quality assessment for stroke specific
Treatments such as endovascular treatment. It will also enable the participating hospitals to
compare the quality of care of their facility. At the same time, B-SPATIAL will provide an
opportunity of scientific evaluation of new therapeutic procedures or specific treatments in
stroke (i.e. reversal of oral anticoagulation in intracerebral hemorrhage or intravenous
thrombolysis), not sufficiently investigated so far. Finally, the B-SPATIAL Registry will
allow for an identification of key quality indicators that assure valid quality assessment
aiming at a reduced documentation load for future quality management.